Abdel-GhaniMustafaAzzouqaMD

PubMed

• 2 citations
  Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.
  Adam M Kase, Abdel-Ghani Azzouqa, Swapna Kochuveettil, Gerardo Colon-Otero
  Cancer Medicine. 2023-04-01
• 174 citations
  Emerging therapeutic agents for advanced non-small cell lung cancer
  Ruqin Chen, Rami Manochakian, Lauren James, Abdel Ghani Azzouqa, Huashan Shi
  Journal of Hematology & Oncology. 2020-05-24
• 2 citations
  Monoclonal antibody utilization characteristics in patients with multiple myeloma.
  Sikander Ailawadhi, Taimur Sher, Abdel Ghani Azzouqa, Zahara Meghji, Tania Jain
  Anti-Cancer Drugs. 2019-09-01

Journal Articles

• Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic  
  Montero AJ, Stevenson J, Guthrie AE, Best C, Goodman LM, Shrotriya S, Azzouqa AG, Parala A, Lagman R, Bolwell BJ et al, J Oncol Pract, 1/1/2016

Abstracts/Posters

• Association of CDKN2A gene alteration with high expression of PD-L1.
  Zhang Y, Marin-Acevedo JA, Azzouqa AG, Manochakian R, Lou Y, Journal of Clinical Oncology, 1/1/2018
• Gemcitabine in combination with Nab-Paclitaxel for treatment of recurrent ovarian cancer; The Mayo Clinic Florida experience.
  Abdel-Ghani Azzouqa, Gerardo Colon-otero, 27th Annual Mayo Clinic Hem/Onc Reviews, Amelia Island, FL, 1/1/2018
• Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma.
  Ailawadhi S, Azzouqa A-G, Meghji Z, Jain T, Diehl N, Gebhardt SP, Shah V, Hodge DO, Patel R, Jani P et al, Blood, 1/1/2017
• Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities.
  Ailawadhi S, Azzouqa A-G, Hodge DO, Cochuyt J, Meghji Z, Patel R, Jani P, Kakar TS, Aggarwal A, Sher T et al, Blood, 1/1/2017
• Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic.
  Montero AJ, Stevenson J, Guthrie AE, Best C, Goodman LM, Shrotriya S, Azzouqa A-G, Parala A, Lagman R, Bolwell BJ et al, Journal of Oncology Practice, 1/1/2016
• Effect of improving guideline-based prophylactic growth factor (pGCSF) use with chemotherapy (CT) on the risk of febrile neutropenia (FN) in non-small cell lung cancer...
  Goodman LM, Moeller M, Dalby CK, Azzouqa A, Guthrie AE, Earl MA, Velcheti V, Shapiro MA, Pennell NA, Stevenson J, Journal of Clinical Oncology, 1/1/2015
• Join now to see all

Lectures

• Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC). 
  2019 ASCO Annual Meeting - 6/1/2019
• Secondary Acute pro myelocytic leukemia. 
  Amelia Island, FL - 1/1/2017
• Biclonal leukemia. 
  Tampa, FL
• Lung Cancer Biology, Diagnosis, Prognosis and Treatment 
  Jacksonville, FL
• Thrombocytopenia, Deferential Diagnosis, and Management Strategies 
  Jacksonville, FL
• Molecular Biology Introduction 
  Jacksonville, FL
• Join now to see all